Eric Warren, Chief Commercial Officer at Esperion Therapeutics, Inc. (ESPR), sold 108 shares at $0.98 ($106) on 2025-04-17, disclosed to the SEC on 2025-04-21.
Open-market sale of $106 ESPR by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| MLYS | SELL | 2026-07-23 | $200K | — | Filing → |
| MLYS | SELL | 2026-06-30 | $2.7M | — | Filing → |
| ESPR | SELL | 2025-03-19 | $4K | — | Filing → |